We are live on ! Find out more
GMAB icon

Genmab
GMAB

233 hedge funds and large institutions have $1.67B invested in Genmab in 2023 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 56 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 21

71% more repeat investments, than reductions

Existing positions increased: 96 | Existing positions reduced: 56

9% more funds holding

Funds holding: 213 → 233 (+20)

8.68% more ownership

Funds ownership: 63.15% → 71.83% (+8.7%)

6% more capital invested

Capital invested by funds: $1.59B → $1.67B (+$89.5M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

22% less call options, than puts

Call options by funds: $1.61M | Put options by funds: $2.07M

Holders
233
Holders Change
+20
Holders Change %
+9.39%
% of All Funds
3.7%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
96
Reduced
56
Closed
21
Calls
$1.61M
Puts
$2.07M
Net Calls
-$459K
Net Calls Change
-$379K

Top Buyers

Rank Fund Capital Flow
1
HL
Harding Loevner
New Jersey
+$116M
2
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
3
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$17.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$12.8M
5
Northern Trust
Northern Trust
Illinois
+$9.68M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$14.8M
2
Macquarie Group
Macquarie Group
Australia
-$13.2M
3
Jane Street
Jane Street
New York
-$6.57M
4
Two Sigma Investments
Two Sigma Investments
New York
-$5.13M
5
ACM
Aquilo Capital Management
California
-$4.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
76
Cubist Systematic Strategies
Connecticut
$1.08M -$2.21M -57,928 -65%
Prudential Financial
77
Prudential Financial
New Jersey
$1.06M +$329K +8,644 +40%
LWAM
78
Legacy Wealth Asset Management
Minnesota
$1.04M +$516K +13,544 +85%
CGPCS
79
Capital Group Private Client Services
California
$1.01M – – –
ACM
80
Ativo Capital Management
Illinois
$1M -$11.4K -299 -1%
UCFA
81
United Capital Financial Advisors
Texas
$982K -$31K -814 -3%
VAS
82
Vestmark Advisory Solutions
Massachusetts
$979K -$403K -10,584 -28%
GA
83
Geller Advisors
New York
$963K -$1.91K -50 -0.2%
Balyasny Asset Management
84
Balyasny Asset Management
Illinois
$936K +$723K +18,963 +250%
Creative Planning
85
Creative Planning
Kansas
$923K +$239K +6,281 +32%
BCI
86
Brinker Capital Investments
Pennsylvania
$921K +$279K +7,322 +39%
OPS
87
Orion Portfolio Solutions
Nebraska
$921K +$279K +7,322 +39%
NA
88
Navellier & Associates
Nevada
$903K +$56.6K +1,485 +6%
GD
89
Grandfield & Dodd
New York
$882K +$125K +3,285 +15%
VWM
90
Venturi Wealth Management
Texas
$864K +$1.94K +51 +0.2%
CL
91
CIM LLC
New York
$856K +$7.2K +189 +0.8%
BFG
92
Bleakley Financial Group
New Jersey
$846K -$18.1K -475 -2%
SS
93
Simplicity Solutions
Minnesota
$846K -$17.2K -452 -2%
BNP Paribas Asset Management
94
BNP Paribas Asset Management
France
$836K – – –
MSAM
95
Moloney Securities Asset Management
Missouri
$801K -$286K -7,500 -25%
SFA
96
Sequoia Financial Advisors
Ohio
$771K +$59.3K +1,557 +8%
Citigroup
97
Citigroup
New York
$760K +$490K +12,863 +148%
Envestnet Portfolio Solutions
98
Envestnet Portfolio Solutions
Illinois
$721K +$779K +20,441 New
Mirae Asset Global Investments
99
Mirae Asset Global Investments
South Korea
$700K -$75.7K -1,987 -9%
Rockefeller Capital Management
100
Rockefeller Capital Management
New York
$667K +$188K +4,945 +35%
2 3
4
5 6

GMAB Hedge Fund Activity: Q3 2023 in Review

233 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2023, worth a combined $1.67B — up 5.6% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new GMAB positions and 21 closed out — a net gain of 20 holders — while 96 added to existing stakes and 56 trimmed.

The largest buyer was Harding Loevner, adding an estimated $116M. The largest seller was BlackRock, cutting an estimated $14.8M.

  • 233 institutional investors held Genmab (GMAB) as of Q3 2023, up from 213 in Q2 2023.
  • Funds reported $1.67B of Genmab stock for Q3 2023, up 5.6% quarter-over-quarter.
  • 41 funds opened new Genmab positions in Q3 2023 and 21 closed out, a net change of +20 holders.
  • The largest Genmab buyer in Q3 2023 was Harding Loevner, an estimated $116M added.
  • The largest Genmab seller in Q3 2023 was BlackRock, an estimated $14.8M sold.

Based on aggregated 13F filings for Q3 2023.